January 11, 2019 06:41 AM EST
Pharma

J&J hikes US prices for a bas­ket of drugs, in­clud­ing cer­tain top-sell­ers — Reuters

Natalie Grover

Reporter

As De­mo­c­ra­t­ic mem­bers of Con­gress pro­posed leg­is­la­tion to curb soar­ing drug prices on Thurs­day, the world’s biggest drug­mak­er by rev­enue John­son & John­son …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times